Trials / Completed
CompletedNCT04452019
Use of Standing Frame and "Innowalk Pro" in Patients With TBI
Responses on Use of Standing Frame and "Innowalk Pro" in Subacute Patients With Severe Functional Deficits Due to Acquired Brain Injury.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Sunnaas Rehabilitation Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study will explore physical and physiological responses to mobilization of patients with acquired brain injuries in subacute phase using a classic standing frame and a standing device with simultaneous passive movement of legs, "Innowalk Pro".
Detailed description
Several studies underline the importance of early mobilization of patients with brain injuries, leading to shorter hospital stays, less contractures, and improved general function. The routine mobilization treatment in the rehabilitation of patients with severe brain injuries in Sunnaas Rehabilitation Hospital is initial use of a tilt table where tilt angle is gradually increased, and when tolerated, standing in a classic standing frame where the patient's lower body is fixed to the device in an upright standing position. "Innowalk Pro" is a robotic standing device where legs are fixed, but passively moved by electric motors in an upright standing position. An assumption is that standing in "Innowalk Pro" might be better tolerated at an earlier stage of rehabilitation than standing in a classic standing frame.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Use of standard standing frame | Two training sessions in a standard standing frame, max 30 min. pr. session |
| DEVICE | Use of a new device; Innowalk Pro | Two training sessions in Innowalk Pro, max 30 min pr. session |
Timeline
- Start date
- 2020-10-19
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2020-06-30
- Last updated
- 2023-04-14
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT04452019. Inclusion in this directory is not an endorsement.